162 related articles for article (PubMed ID: 38612715)
1. Hinokitiol Inhibits Breast Cancer Cells In Vitro Stemness-Progression and Self-Renewal with Apoptosis and Autophagy Modulation via the CD44/Nanog/SOX2/Oct4 Pathway.
Chiang YF; Huang KC; Chen HY; Hamdy NM; Huang TC; Chang HY; Shieh TM; Huang YJ; Hsia SM
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612715
[TBL] [Abstract][Full Text] [Related]
2. Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial Cancer Cell Lines (Ishikawa, HEC-1A, KLE).
Chen HY; Cheng WP; Chiang YF; Hong YH; Ali M; Huang TC; Wang KL; Shieh TM; Chang HY; Hsia SM
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361036
[TBL] [Abstract][Full Text] [Related]
3. Different Cell Responses to Hinokitiol Treatment Result in Senescence or Apoptosis in Human Osteosarcoma Cell Lines.
Yang SC; Chen HY; Chuang WL; Wang HC; Hsieh CP; Huang YF
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163553
[TBL] [Abstract][Full Text] [Related]
4. Hinokitiol induces autophagy in murine breast and colorectal cancer cells.
Wang WK; Lin ST; Chang WW; Liu LW; Li TY; Kuo CY; Hsieh JL; Lee CH
Environ Toxicol; 2016 Jan; 31(1):77-84. PubMed ID: 25044443
[TBL] [Abstract][Full Text] [Related]
5. Hinokitiol induces cell death and inhibits epidermal growth factor-induced cell migration and signaling pathways in human cervical adenocarcinoma.
Wang CC; Chen BK; Chen PH; Chen LC
Taiwan J Obstet Gynecol; 2020 Sep; 59(5):698-705. PubMed ID: 32917321
[TBL] [Abstract][Full Text] [Related]
6. Hinokitiol, a metal chelator derived from natural plants, suppresses cell growth and disrupts androgen receptor signaling in prostate carcinoma cell lines.
Liu S; Yamauchi H
Biochem Biophys Res Commun; 2006 Dec; 351(1):26-32. PubMed ID: 17055455
[TBL] [Abstract][Full Text] [Related]
7. Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation.
Ouyang WC; Liao YW; Chen PN; Lu KH; Yu CC; Hsieh PL
Cancer Chemother Pharmacol; 2017 Aug; 80(2):411-419. PubMed ID: 28685346
[TBL] [Abstract][Full Text] [Related]
8. Hinokitiol Inhibits Melanogenesis via AKT/mTOR Signaling in B16F10 Mouse Melanoma Cells.
Tsao YT; Huang YF; Kuo CY; Lin YC; Chiang WC; Wang WK; Hsu CW; Lee CH
Int J Mol Sci; 2016 Feb; 17(2):248. PubMed ID: 26901194
[TBL] [Abstract][Full Text] [Related]
9. Hinokitiol Inhibits Migration of A549 Lung Cancer Cells via Suppression of MMPs and Induction of Antioxidant Enzymes and Apoptosis.
Jayakumar T; Liu CH; Wu GY; Lee TY; Manubolu M; Hsieh CY; Yang CH; Sheu JR
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29565268
[TBL] [Abstract][Full Text] [Related]
10. Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells.
Li LH; Wu P; Lee JY; Li PR; Hsieh WY; Ho CC; Ho CL; Chen WJ; Wang CC; Yen MY; Yang SM; Chen HW
PLoS One; 2014; 9(8):e104203. PubMed ID: 25105411
[TBL] [Abstract][Full Text] [Related]
11. Hinokitiol, a tropolone derivative, inhibits mouse melanoma (B16-F10) cell migration and in vivo tumor formation.
Huang CH; Lu SH; Chang CC; Thomas PA; Jayakumar T; Sheu JR
Eur J Pharmacol; 2015 Jan; 746():148-57. PubMed ID: 25449038
[TBL] [Abstract][Full Text] [Related]
12. p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function.
Liu S; Yamauchi H
Cancer Lett; 2009 Dec; 286(2):240-9. PubMed ID: 19631451
[TBL] [Abstract][Full Text] [Related]
13. Hinokitiol protects primary neuron cells against prion peptide-induced toxicity via autophagy flux regulated by hypoxia inducing factor-1.
Moon JH; Lee JH; Lee YJ; Park SY
Oncotarget; 2016 May; 7(21):29944-57. PubMed ID: 27074563
[TBL] [Abstract][Full Text] [Related]
14. Hinokitiol induces DNA demethylation via DNMT1 and UHRF1 inhibition in colon cancer cells.
Seo JS; Choi YH; Moon JW; Kim HS; Park SH
BMC Cell Biol; 2017 Feb; 18(1):14. PubMed ID: 28241740
[TBL] [Abstract][Full Text] [Related]
15. Hinokitiol reduces tumor metastasis by inhibiting heparanase via extracellular signal-regulated kinase and protein kinase B pathway.
Wu YJ; Hsu WJ; Wu LH; Liou HP; Pangilinan CR; Tyan YC; Lee CH
Int J Med Sci; 2020; 17(3):403-413. PubMed ID: 32132875
[TBL] [Abstract][Full Text] [Related]
16. Loss of miR-6844 alters stemness/self-renewal and cancer hallmark(s) markers through CD44-JAK2-STAT3 signaling axis in breast cancer stem-like cells.
Prajapati KS; Kumar S
J Cell Biochem; 2023 Aug; 124(8):1186-1202. PubMed ID: 37436061
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative Activity of Hinokitiol, a Tropolone Derivative, Is Mediated via the Inductions of p-JNK and p-PLCĪ³1 Signaling in PDGF-BB-Stimulated Vascular Smooth Muscle Cells.
Yang PS; Wang MJ; Jayakumar T; Chou DS; Ko CY; Hsu MJ; Hsieh CY
Molecules; 2015 May; 20(5):8198-212. PubMed ID: 25961161
[TBL] [Abstract][Full Text] [Related]
18. Hinokitiol inhibits compound action potentials in the frog sciatic nerve.
Magori N; Fujita T; Kumamoto E
Eur J Pharmacol; 2018 Jan; 819():254-260. PubMed ID: 29225186
[TBL] [Abstract][Full Text] [Related]
19. Hinokitiol suppresses growth of B16 melanoma by activating ERK/MKP3/proteosome pathway to downregulate survivin expression.
Wei KC; Chen RF; Chen YF; Lin CH
Toxicol Appl Pharmacol; 2019 Mar; 366():35-45. PubMed ID: 30684529
[TBL] [Abstract][Full Text] [Related]
20. Hinokitiol-induced decreases of tyrosinase and microphthalmia-associated transcription factor are mediated by the endoplasmic reticulum-associated degradation pathway in human melanoma cells.
Oyama T; Ogawa H; Shirai Y; Abe H; Kamiya T; Abe T; Tanuma SI
Biochimie; 2022 Jan; 192():13-21. PubMed ID: 34536557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]